Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute DecompensationLucie Simonis, Georg Semmler, Benedikt Hofer et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 5
Diagnostic and Clinical Implications of High Spleen‐To‐Liver Stiffness Ratio in <scp>MASH</scp> —A Prospective, Comparative StudyChristian Sebesta, David Bauer, Mathias Jachs et al.|Liver International|2025Cited by 5
Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With CirrhosisNina Dominik, Benedikt Hofer, Benedikt Simbrunner et al.|Liver International|2025Cited by 4
<scp>GDF</scp> ‐15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical OutcomesBenedikt Hofer, Thomas Gremmel, T. Perkmann et al.|Liver International|2026Cited by 3
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and DeathMathias Jachs, Mattias Mandorfer, Tânia Carvalho et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 3